Under the authorization, the company can repurchase up to $500 million of its common stock through March 16, 2027, according to a March 11 news release from Patterson.
The new approval replaces the previous repurchase authorization, which was expiring with $194.9 million remaining.
Patterson’s board also announced a quarterly cash dividend of $0.26 per share, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.